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South AmericaWe explored the cutaneotropic HPV genetic diversity in 71 subjects from Argentina. New generic primers
(CUT) targeting 88 mucosal/cutaneous HPV were designed and compared to FAP primers. Overall, 69
different HPV types/putative types were identiﬁed, being 17 of them novel putative types. Phylogenetic
analysis of partial L1 sequences grouped 2 novel putative types in the Beta-PV, 14 in the Gamma-PV and 1 in
the Mu-PV genera. CUT primers showed broader capacity than FAP primers in detecting different genera/
species and novel putative types (pb0.01). Using overlapping PCR, the full-length genome of a Beta-PV
putative type was ampliﬁed and cloned. The new virus, designated HPV 115, encodes ﬁve early genes and
two late genes. Phylogenetic analysis indicated HPV 115 as the most divergent type within the genus Beta-PV
species 3. This report is the ﬁrst providing data on cutaneous HPVs circulating in South America and expands
our knowledge of the Papillomaviridae family.
© 2009 Elsevier Inc. All rights reserved.Introduction
Papillomaviruses are small non-enveloped DNA tumor viruses
with a genome of nearly 8000 base pairs. PVs are host speciﬁc and
have been found in more than 20 different mammalian and avian
species (de Villiers et al., 2004). Presently, more than 110 human PVs
(HPVs) types have been completely sequenced and are classiﬁed into
mucosal/genital and cutaneous types based on sequence analyses and
clinical manifestations (Bernard et al., 2006). HPVs have been divided
into ﬁve genera according to the phylogenetic relationships of their
complete L1 gene sequences (de Villiers et al., 2004). The mucosal/
genital HPV types belong to the Alpha-PV genus and can be divided
into low-risk and high-risk types as inferred from their association
with benign and malignant anogenital lesions (zur Hausen, 2002).irología, Instituto de Biología
de Ciencias Bioquímicas y
ipacha 531, (2000) Rosario,
iología Molecular y Celular de
y Farmacéuticas, Universidad
tina. Fax: +54 341 439 0465.
ll rights reserved.Cutaneous HPVs represent more than 75% of the HPVs described to
date and are distributed into ﬁve different genera: Alpha-, Beta-,
Gamma-, Mu-, and Nu-PV (de Villiers et al., 2004).
High-risk mucosa/genital HPV types are the causative infectious
agents of several anogenital cancers, such as cervical cancer (zur
Hausen, 2002), by their ability to deregulate host-cell apoptosis and
cell-cycle pathways (Steenbergen et al., 2005). In contrast, the
involvement of cutaneous HPV types in human carcinogenesis and
its pathological signiﬁcance is still unclear. HPV DNA from cutaneous
types has been detected in benign warts, in premalignant lesions and
in nonmelanoma skin cancer (NMSC) from immunosuppressed and
immunocompetent subjects (Forslund et al., 1999; Forslund et al.,
2007), but also in healthy skin from the general population
(Antonsson et al., 2003; Chen et al., 2008).
NMSC developsmostly in sun-exposed skin and this fact highlights
the role of UV radiation as a major environmental risk factor for the
development of epithelial skin cancers (Nindl et al., 2007). Genomes
of the cutaneous HPVs are commonly detected in the tumors (Akgul et
al., 2006) and in sun-exposed healthy skin (Antonsson et al., 2000;
Antonsson et al., 2003), suggesting a link between HPV and UV
radiation as co-factors in the development of NMSCs (Akgul et al.,
2006; Feltkamp et al., 2008).
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broad range of HPV types in healthy skin as well as in NMSC (Forslund
et al., 1999; Patel et al., 2008). Most cutaneous HPV types presently
identiﬁed have been detected by nested PCRs using two pairs of
degenerate primers (Forslund et al., 2003; Forslund et al., 2007). Of
them, the FAP primer system (Forslund et al., 1999; Forslund et al.,
2003) has been a successful approach in identifying many HPV types
(Chen et al., 2007; Chen et al., 2008; Vasiljevic et al., 2007; Vasiljevic et
al., 2008) and more than 150 subgenomic amplicons of putative HPV
types (FA sequences) from skin and mucosal samples (Antonsson et
al., 2000; Forslund et al., 1999; Forslund et al., 2003; Forslund et al.,
2004; Forslund, 2007; Forslund et al., 2007). However, the extraor-
dinary diversity of HPV types infecting the skin reveals the need of
primer sets capable of amplifying an even more diverse range of HPV
types before a role for HPV infection in the pathogenesis of skin
cancers can be excluded.
Most epidemiological studies have reported HPV prevalence and
type spectrum in different kinds of skin samples from Europe
(Antonsson et al., 2000; Antonsson et al., 2003; Forslund et al.,
2007), Australia (Chen et al., 2008; Forslund et al., 2003), North
America (Patel et al., 2008), Asia (Antonsson et al., 2003) and Africa
(Antonsson et al., 2003). Yet, no studies describing the cutaneous
HPVs circulating in South America have been reported.
Taking into account that UV radiation is an important environ-
mental risk factor for the development of NMSC and the link between
UV and HPV infection, South America constitutes an interesting
geographical region to explore the spectrum of HPV circulating
genotypes. With this in mind and in order to provide an alternative
tool for the ampliﬁcation of a broad range of HPV types, we designed
new generic primers targeting most mucosal/genital and cutaneous
HPVs within all genera and compared them to the widely used FAP
primers (Forslund et al., 1999; Forslund et al., 2003). With these
instruments we explore the HPV prevalence and type spectrum in a
variety of skin diseases as well as in sun-exposed and non-sun-
exposed healthy skin areas from immunocompetent subjects from
Argentina. This is the ﬁrst study providing data on the HPVs
circulating in South America and it allowed the identiﬁcation of 17
novel putative HPV types and the full characterization of the HPV 115
genome, a novel Beta-PV species 3.
Results
In total, 71 immunocompetent patients were recruited (44 males
and 27 females) with a median age of 54 years (range, 19–89 years)
and the following skin phototypes: 6% I (4/71), 66% II (47/71), 27% III
(19/71) and 1% IV (1/71). There were 18 patients with seborrhoeic
keratoses (SK), 10 with actinic keratoses (AK), 5 with NMSC (2 basal
cell carcinomas and 3 squamous cell carcinomas), 15 with benign skin
lesions (3 soft ﬁbromas, 2 verrucous nevus, 1 ﬁbrokeratoma, 1 dermal
melanocytic nevus, 1 lymphoma, 1 psoriasis vulgaris, 1 acantholytic
acanthoma, 1 lichen hypertrophic, 1 trichilemmal horn, 1 stratum
corneum, 1 ﬁbrous papule of the nose, 1 cytotoxic dermatitis), and 23
with viral warts (14 cutaneous and 9 external anogenital warts).
Three hundred ﬁfty-ﬁve specimens were collected from lesions and
healthy skin areas from all patients but only β-globin-positive
samples (n=304) were considered for HPV analysis. They included
samples from 69 sun-exposed healthy skin areas (A), 48 non-sun-
exposed healthy skin areas (B), 63 perilesion areas (C), 61 lesion areas
(D), and 63 lesion biopsies (E).
HPV DNA detection and type identiﬁcation by CUT and FAP
primer systems
The frequency of HPV infection was determined by the presence of
visible bands of the ampliﬁed products derived from CUT or FAP
primer systems after electrophoresis in 2% agarose gel. Overall, HPVDNAwas present in 55% of the analyzed samples (167/304). HPV DNA
was detectedmore often by FAP than by CUT primer system (128/304
vs. 94/304, respectively), but only 55 samples were HPV-positive by
both. In addition, 137 specimens tested negative for HPV DNA by both
primer systems.
In order to determine the HPV types detected by each primer
system in our samples, DNA sequence analysis was performed.
Overall, 69 different HPV types/putative types were identiﬁed with
both primer systems (Fig. 2). CUT primer system detected 22 different
HPV types or putative types, 9 of which (41%) corresponded to novel
putative types (GC05, GC06, GC08, GC09, GC10, GC11, GC12, GC13,
GC14). FAP primer system identiﬁed 37 different HPV types or
putative types, 5 of them (14%) being novel putative types (GC01,
GC03, GC15, GC16, GC17). The differential capacity of CUT primers in
detecting novel putative viruses with respect to FAP primers was
found to be signiﬁcant (pb0.01). Finally, only 10 different types were
detected by both primer systems, 3 of them being novel putative types
(GC02, GC04, GC07).
Several variants and subtypes of HPV types and putative types
were found with each primer system but they were not considered in
the analysis. Among the 17 novel putative HPV types, GC07 was found
as 4 variants [GC07.1, GC07.2 (98.4% identity), GC07.3 (98.4%
identity), GC07.4 (98.9% identity)], GC12 as 3 variants [GC12.1,
GC12.2 (99.5% identity), GC12.3 (98.9% identity)], and GC02 as two
subtypes [GC02 and GC02b (93.6% identity)]. All variants and
subtypes of the novel putative HPV types were detected with the
CUT primer system, except for the GC02 subtypes and the GC07.1
variant that were detected by FAP primers as well (data not shown).
Table 1 provides detailed data about the HPV types/putative types
detected by each primer system. CUT primer system better detected
viruses belonging to genus Alpha-PV (9 viruses by CUT vs. 1 virus by
FAP) while it was worse than FAP primer system in detecting those in
genus Beta-PV (7 viruses by CUT vs. 34 viruses by FAP). Both systems
showed similar capacity in detecting viruses from genus Gamma-PV
(16 viruses by CUT vs. 11 viruses by FAP) and FAP primer assay was
the only system able to identify a novel putative HPV type (GC03)
belonging to genus Mu-PV. Interestingly, only 10 HPV types/putative
types were detected by both primer systems (HPV 6, HPV 14D, FA23,
FA37, HPV 110, GC02, HPV 50, FA91, GC04, GC07). The capacity of each
primer system to detect HPVs from different genera and species is
summarized in Fig. 3.
Sequence comparisons of all HPV type/putative type L1 ORF
fragments identiﬁed by any primer system showed that 33 (48%)
were found to be previously characterized HPV types, 19 (27%) were
earlier described putative HPV types and 17 (25%) were novel
putative HPV types (Table 1). Of them, 36 belonged to the genus Beta-
PV, 23 to the genus Gamma-PV, 1 to the genus Mu-PV, and 9 to the
genus Alpha-PV, harboring also genital HPV types. The most
frequently detected types were HPV 2 of genus Alpha-PV species 4
and HPV 20 of genus Beta-PV species 1, both types identiﬁed in 17
samples each. Among novel putative HPV types, GC02 from genus
Beta-PV was the most frequently found (10 samples), followed by the
Gamma-PVs GC07 (4 samples) and GC12 (3 samples).Frequency of HPV types according to patients and samples
In total, 87% (62 of 71) of the patients harbored HPVDNA in at least
one of the samples. Table 2 summarizes the results of HPV detection
and type distribution of skin samples from the different sites studied
in each group of patients. HPV DNA prevalence in healthy skin was
signiﬁcantly higher in sun-exposed areas with respect to non-sun-
exposed areas (p=0.0027). In contrast, the difference in HPV DNA
prevalence between perilesion and lesion swab samples was not
signiﬁcant, although both sites had signiﬁcantly higher HPV DNAwith
respect to lesion biopsy samples (pb0.0001).
Table 1
HPV types/putative types detected by FAP and CUT primer systems.
HPV genus HPV species HPV/ candidates types Closest related type (%)a FAP CUT FAP and CUT Total
Alpha-PV 2 HPV 10 0 6 6
2 HPV 28 0 2 2
3 HPV 62 0 1 1
3 HPV cand 89 0 1 1
4 HPV 2 0 17 17
8 HPV 7 0 2 2
8 HPV 43 0 8 8
10 HPV 6b 2 15 2c 15
10 HPV 11b 0 10 10
Beta-PV 1 HPV 5 9 0 9
1 HPV 8 11 0 11
1 HPV 12 2 0 2
1 HPV 14D 6 1 1c 6
1 HPV 19 12 0 12
1 HPV 20 17 0 17
1 HPV 21 15 0 15
1 HPV 24 10 0 10
1 HPV 47 4 0 4
1 HPV 93 5 0 5
1 FA14 HPV 24 (76%) 2 0 2
1 FA23 HPV 20 (80%) 2 2 1c 3
1 FA25 HPV 5 (76%) 4 0 4
1 FA37 HPV 5 (78%) 3 1 1d 4
1 FA119 HPV 24 (81%) 8 0 8
1 FA127 HPV 20 (75%) 2 0 2
1 FA132 HPV 5 (75%) 9 0 9
2 HPV 9 1 0 1
2 HPV 15 1 0 1
2 HPV 22 0 1 1
2 HPV 23 1 0 1
2 HPV 37 1 0 1
2 HPV 38 5 0 5
2 HPV 80 1 0 1
2 HPV 107 1 0 1
2 HPV 110 3 1 1c 3
2 HPV 111 1 0 1
2 FA16 HPV 23 (81%) 4 0 4
2 FA53 HPV 23 (81%) 0 2 2
2 FA116 HPV 107 (80%) 2 0 2
2 FA118 HPV 23 (83%) 1 0 1
2 Vs92-1 HPV 110 (81%) 1 0 1
2 GC17 HPV 110 (81%) 1 0 1
3 HPV 49 1 0 1
3 GC02 HPV 49 (74%) 2 10 2c 10
5 HPV 96 5 0 5
Gamma-PV 1 FA89 HPV 95 (72%) 0 2 2
2 FA27 HPV 50 (82%) 0 2 2
3 HPV 50 1 2 1d 3
3 FA8 HPV 50 (72%) 1 0 1
Un HPV 75 1 0 1
Un FA62 HPV 60 (71%) 0 1 1
Un FA66 HPV 50 (68%) 2 0 2
Un FA91 HPV 48 (70%) 4 2 2c 4
Un FAIMVS9 HPV 4 (73%) 1 0 1
Un GC01 HPV 95 (76%) 1 0 1
Un GC04 HPV 60 (85%) 2 1 1c 2
Un GC05 HPV 4 (72%) 0 1 1
Un GC06 HPV 60 (70%) 0 1 1
Un GC07d HPV 60 (71%) 2 4 2c 4
Un GC08 HPV 4 (70%) 0 2 2
Un GC09 HPV 50 (68%) 0 2 2
Un GC10 HPV 4 (70%) 0 2 2
Un GC11 HPV 48 (82%) 0 1 1
Un GC12 HPV 50 (72%) 0 3 3
Un GC13 HPV 50 (70%) 0 1 1
Un GC14 HPV 88 (70%) 0 2 2
Un GC15 HPV 4 (74%) 1 0 1
Un GC16 HPV 65 (72%) 2 0 2
Mu-PV 1 GC03 HPV 1a (71%) 1 0 1
Total 174 109 14 271
Un: species not included in the current HPV taxonomy (de Villiers et al., 2004).
a Putative HPV types are shown together with the previously characterized HPV types to which they show the closest DNA sequence homology.
b HPV types identiﬁed in viral warts from external male and female genitalia.
c The same HPV/putative type was found in the same sample.
d The same HPV/putative type was found in different samples.
207D. Chouhy et al. / Virology 397 (2010) 205–216
Table 2
HPV DNA detection with CUT and FAP primers from different sites.
Diagnosis
No. of patients
Site samples Total
A B C D E
SK
n=18
Samples, n 17 10 15 14 15 71
Prevalence, % 88 (15/17) 50 (5/10) 87 (13/15) 71 (10/14) 27 (4/15) 66 (47/71)
Multiple infection, % 53 (9/17) 10 (1/10) 47 (7/15) 21 (3/14) 0 (0/15) 28 (20/71)
No. of viruses 33 6 20 13 4 76
Genera, % Alpha: 15
Beta: 64
Gamma: 21
Beta: 83
Gamma: 17
Alpha: 15
Beta: 75
Gamma: 10
Alpha: 31
Beta: 69
Alpha: 75
Beta: 25
AK
n=10
Samples, n 9 6 9 9 8 41
Prevalence, % 78 (7/9) 33 (2/6) 56 (5/9) 56 (5/9) 0 (0/8) 46 (19/41)
Multiple infection, % 22 (2/9) 6 (1/6) 33 (3/9) 44 (4/9) 0 (0/8) 24 (10/41)
No. of viruses 10 4 12 12 0 38
Genera, % Beta: 80
Gamma: 20
Beta: 100 Alpha: 8
Beta: 61
Gamma: 31
Beta: 67
Gamma: 33
None
VW
n=23
Samples, n 23 17 22 22 22 106
Prevalence, % 65 (15/23) 24 (4/17) 73 (16/22) 77 (17/22) 55 (12/22) 60 (64/106)
Multiple infection, % 26 (6/23) 6 (1/17) 36 (8/22) 14 (3/22) 5 (1/22) 18 (19/106)
No. of viruses 24 5 26 21 13 89
Genera, % Alpha: 29
Beta: 58
Gamma: 13
Alpha: 20
Beta: 80
Alpha: 42
Beta: 50
Gamma: 8
Alpha: 62
Beta: 33
Gamma: 5
Alpha: 85
Beta: 15
CC
n=5
Samples, n 5 2 5 4 3 19
Prevalence, % 60 (3/5) 50 (1/2) 100 (5/5) 75 (3/4) 0 (0/3) 63 (12/19)
Multiple infection, % 40 (2/5) 0 (0/2) 80 (4/5) 25 (1/4) 0 (0/3) 37 (7/19)
No. of viruses 6 1 12 4 0 23
Genera, % Beta: 83
Gamma: 17
Gamma: 100 Alpha: 8
Beta: 8
Gamma: 8
Beta: 100 None
BSL
n=15
Samples, n 16 13 12 12 15 68
Prevalence, % 53 (8/15) 46 (6/13) 58 (7/12) 33 (4/12) 0 (0/15) 37 (25/67)
Multiple infection, % 13 (2/15) 0 (0/13) 33 (4/12) 17 (2/12) 0 (0/15) 12 (8/67)
No. of viruses 15 6 17 7 0 45
Genera, % Beta: 67
Gamma: 27
Mu: 6
Alpha: 33
Beta: 67
Beta: 71
Gamma: 29
Beta: 57
Gamma: 43
None
Total
n=71
Samples, n 69 48 63 61 63 304
Prevalence, % 70 (48/69) 38 (18/48) 73 (46/63) 64 (39/61) 25 (16/63) 55 (167/304)
Multiple infection, % 30 (21/69) 6 (3/48) 41 (26/63) 21 (13/61) 2 (1/63) 21 (64/304)
No. of viruses 86 22 88 58 17 271
Genera, % Alpha: 14
Beta: 66
Gamma: 19
Mu: 1
Alpha: 14
Beta: 77
Gamma: 9
Alpha: 18
Beta: 66
Gamma: 16
Alpha: 30
Beta: 56
Gamma: 14
Alpha: 82
Beta: 18
Alpha: 23
Beta: 61
Gamma: 15
Mu: 1
A: sun exposed healthy skin swab; B: non-sun-exposed healthy skin swab; C: perilesion swab; D: lesion swab; E: lesion biopsy.
SK: seborrheic keratosis; AK: actinic keratosis; VW: viral wart; CC: cutaneous carcinoma; BSL: benign skin lesion.
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sample of 51% of the patients (36/71) and followed the same trend of
HPV prevalence at the different site samples: perilesion areas (41%),
sun-exposed healthy skin areas (30%), lesion swabs (21%), non-sun-
exposed healthy skin areas (6%), and lesion biopsies (2%).
A total of 271 HPV sequences were identiﬁed, mostly in samples
derived from perilesion, lesion and healthy sun-exposed skin swabs.
In contrast, non-sun-exposed healthy skin and lesion biopsies had a
signiﬁcant lesser number of identiﬁed sequences (pb0.001).
Of the 63 lesion biopsies, 47 tested negative for HPV DNA but were
positive for human DNA, indicating that the samples contained DNA of
sufﬁcient quality and quantity for PCR ampliﬁcation. Only patients
with SK and viral warts had positive results for HPV DNA in lesion
biopsies (prevalences of 27% and 55%, respectively), mostly harboring
viruses from the Alpha-PV genus.
In general, Beta-PVs predominated at different sites, except for
lesion biopsies derived from SK patients, and lesion swabs and
biopsies from patients with viral warts in which Alpha-PVs prevailed.
In SK lesion biopsies, the most detectable Alpha-PV type was HPV 2 (2
out of 4 identiﬁed viruses) while HPV 6was themost frequently found
in lesions and lesion biopsies from patients with viral warts (6 in each
of 21 or 13 identiﬁed viruses, respectively), derived mainly fromanogenital warts (Tables 1 and 2). Novel putative types, their variants
and subtypes were found mainly in swab samples from healthy sun-
exposed skin, perilesion and lesion areas. None of themwere found in
lesion biopsies.
Phylogenetic analyses of the novel putative HPV types
We ﬁrst analyzed the taxonomic validity of partial L1 fragments
(CUT and FAP sequences, Bayesian analysiswithMrBayes 3.1 program)
since our phylogenetic approach was different than the one used to
deﬁne the current HPV taxonomy (complete L1 ORF, Phylip version
3.572 and based on a weighted version of the neighbor-joining
analysis) (de Villiers et al., 2004). Validation was done by comparing
the topology of the tree obtained by partial sequences with the tree
obtained by de Villiers et al. (2004). Similar and congruent topologies
were evidenced between both phylogenetic trees (data not shown).
Phylogenetic relationships among novel putative types identiﬁed
in this study and known HPVs from genera Alpha-, Beta-, Gamma-and
Mu-PV are shown in Fig. 4A. Posterior probability values were
generally high (N70) for the nodes of all HPV types within a species,
which shared between 71% and 89% nucleotide identity of the partial
L1 sequence. The distribution of already known sequences into
209D. Chouhy et al. / Virology 397 (2010) 205–216clusters correlated with those previously obtained by other authors
(Chen et al., 2007; de Villiers et al., 2004; Forslund, 2007; Vasiljevic et
al., 2008).
Phylogenetic analyses of GC02 and GC17 novel putative types
classiﬁed them as Beta-PVs (Fig. 4A). Pairwise comparison of types
representative of each species within this genus allowed to assign
the GC02 isolate to species 3 (74.7% sequence identity to HPV 49)
(Fig. 4B). The highest sequence identity of the novel putative type
GC17was observed among reference type HPV 49 (species 3) and HPV
92 (species 4) of Beta-PVs (76.9% to each) (Fig. 4B). Yet, novel GC17
shared an 81% of sequence identity to the recently characterized HPVFig. 1. Generic primer systems for cutaneous HPV detection. (A) Alignments of the forward a
HPV types. Lines and characters represent identical and mismatched nucleotides, respecti
positions of CUT (CUT1Fw: nucleotides 6052 to 6072; CUT1BRv: nucleotides 6406 to 6424) a
to 6073; FAP6319R: nucleotides 6268 to 6291; FAP64: nucleotides 6408 to 6430) (Forslund e
used for phylogenetic analysis in the present study.110 (Vasiljevic et al., 2008) and though considered a new member of
the Beta-PV species 2 (Table 1).
Phylogenetic analyses of the novel putative type GC03 grouped it
as a Mu-PV (Fig. 4A). Nucleotide identity to types representative of
each species within this genus located it in species 1 (71% sequence
identity to HPV 1a) (Fig. 4B).
Among the 14 novel putative HPV types within the genus Gamma-
PV, only GC11 and GC15 could be grouped within species 3 and 1,
respectively (Fig. 4B). The other 12 novel putative HPV types
demonstrated mean nucleotide identities b71% to the HPV types
representing each species (Fig. 4B). Thus, the vast majority of thend reverse primer sequences with the corresponding region in the L1 ORF of 88 selected
vely. Degenerate nucleotides of primers: I=inosine, Y=C/T, R=A/G. (B) Schematic
nd nested FAP-primers (FAP59: nucleotides 5950 to 5970; FAP6085F: nucleotides 6054
t al., 2003) in the L1 ORF of HPV 10. The black boxes indicate the CUT or FAP sequences
210 D. Chouhy et al. / Virology 397 (2010) 205–216novel putative HPV types within the genus Gamma-PV were
segregated outside the deﬁned species.
Identiﬁcation of HPV 115, a novel Beta-PV species 3
We started characterizing isolate GC02, the most prevalent novel
putative HPV type identiﬁed in this study. Using the subgenomic
sequence of GC02 isolate to generate overlapping amplicons (see
“Identiﬁcation of the full-length genome of HPV 115” in the Materials
and Methods section) we obtained the complete genome of HPV 115.
Sequence analysis of the full-length HPV 115 (GenBank accession
No. FJ947080) revealed a genome of 7476 bp with a G + C content
of 41.7% (Fig. 5A). Phylogenetic analysis of the complete L1 ORF
conﬁrmed that HPV 115 represents the fourth HPV type within the
genus Beta-PV species 3 (Fig. 5B), showing the highest identity to HPV
49 (74.6%). Interestingly, HPV 115 showed a low similarity through-
out the genome respect to the three already known types HPV 49, HPV
75 and HPV 76, with the exception of E1, L1 and L2 ORFs (Fig. 5C). This
genetic diversity, together with its position in the branch of
the phylogenetic tree (Fig. 5B), suggests HPV 115 may be related to
a common ancestor of the three already known types within genus
Beta-PV species 3.
As expected, the genome of the novel characterized Beta-PV type
contained seven ORFs (Figs. 5A and C), potentially encoding ﬁve early
genes (E6, E7, E1, E2 and E4) and two late genes (L2 and L1). The
upstream regulatory region (URR) of HPV 115, containing cis-
responsive elements between the L1 and E6 ORFs, consisted of 396
bp which is within the expected range for the genus Beta-PV
(Vasiljevic et al., 2007). Within the URR, a TATA box (TATAA) was
identiﬁed as well as three putative binding sites for E2 (ACCN6GGT)
and three putative binding sites for NF-1 (TTGGC).
The putative proteins of the novel HPV type also showed typical
domains. The E6 protein, contained two conserved zinc-binding
domains, CXXC(X)29CXXC, separated by 36 aa, identical to other E6
HPV proteins (Ullman et al., 1996). No PDZ (PSD-95/DLG/ZO1)
binding sites were found in the putative HPV 115 E6 protein, in
agreement to the observed for other cutaneous HPVs (Pim et al.,
2002). The E7 protein of HPV 115 contained only the second CXXC
motif, with a CXXXC motif 29 amino acids upstream. The E7 ORF also
contained a pRb-binding motif (LXCXE) (Radulescu et al., 1995).
Analysis of the E1 coding sequence showed a typical ATP-binding site
of the ATP-dependent helicase (consensus: GXXXXGKT/S; HPV 115
GPPDCGKT) (Titolo et al., 1999).
Discussion
In contrast to the mucosal/genital HPV types, which belong to the
same phylogenetic group, the cutaneous HPVs show a greater genetic
heterogeneity and are spread out into ﬁve genera (de Villiers et al.,
2004). This intrinsic diversity and their persistence at low levels all
over the skin make necessary the application of highly sensitive
ampliﬁcation techniques together with combined broad spectrum
primer systems to cover most HPV types for comprehensive analysis.Fig. 2. Differential capacity of CUT and FAP primer systems for HPV types/novel
putative types detection.In this work we designed a new generic primer system from two
relatively conserved regions of the L1 ORF sequences of 88
characterized HPVs from the ﬁve genera in which cutaneous types
are distributed (Fig. 1A). The CUT primer system is a cocktail of
different amounts of degenerate oligonucleotides including four
forward and one reverse primer. This approach assured the detection
of a broad spectrum of HPVs by lowering the number of mismatches
among primers and HPV sequences. In fact, CUT primers could detect
eight HPV types from the Alpha-PV genus (HPV 2, 6, 7, 10, 11, 28, 43,
and cand 89) with no mismatches, three HPVs from Alpha-, Beta- and
Gamma-PV genera showing one mismatch (HPV cand 62, HPV 110
and HPV 50, respectively), and two Beta-PVs presenting two
mismatches (HPV 14D and HPV 22) respect to the forward and
reverse oligonucleotides (Table 1 and Fig. 1A).
The capacity for HPV detection and type identiﬁcation of CUT
primers was compared to the FAP primers (Forslund et al., 1999;
Forslund et al., 2003) using in both cases a highly sensitive
ampliﬁcation technique with reduced risk of contamination (Walsh
et al., 2001) and successfully applied for the detection of cutaneous
HPVs (Forslund et al., 2003; Forslund et al., 2007). Both methods
optimized in the described conditions showed identical sensitivities,
allowing the detection of 10 copies of certain cloned HPV genomes.
With this approach, we tested a variety of samples from skin diseases
as well as from sun-exposed and non-sun-exposed healthy skin areas
from the same individuals. CUT primers were less efﬁcient than FAP
primers in detecting HPV DNA (94/304 vs. 128/304, respectively) but
appeared to have a differential speciﬁcity. In fact, only 55 samples
were HPV-positive with both primer systems. This observation was
further veriﬁed by DNA sequence analysis of the FAP and CUT
amplicons. A total of 69 different HPV types/putative types were
identiﬁed but only 10 were detected by both primer systems (Fig. 2,
Table 1). Moreover, in the 55 samples that were HPV-positive by both
primer systems, the same virus was identiﬁed in only 12 of them.
Although CUT primers were able to identify a smaller number of
viruses than FAP primers (22 vs. 37, respectively), they were more
efﬁcient in detecting novel putative types (9 vs. 5, respectively;
pb0.01). The same was true for the variants and subtypes found of
these novel putative HPV types. Previous studies have identiﬁedmany
putative types by using FAP primers (Antonsson et al., 2000;
Antonsson et al., 2003; Forslund et al., 1999; Forslund et al., 2004;
Forslund, 2007) and several of these have been detected by CUT
primers as well (Table 1). We can speculate that FAP primers may
have reached a limit in their capacity in detecting new viruses.
Therefore, the CUT primer system could be applied for the analysis of
previously characterized skin samples as an additional tool to
complete the whole picture of the circulating PVs among humans.
One ﬁnding of our study was the identiﬁcation of ﬁve novel
putative HPV types not previously found with FAP primers in other
parts of the world (GC01, GC03, GC15, GC16, GC17), that may be
linked to the Argentinean population (Table 1). Further isolation and
identiﬁcation of novel putative viruses from other regions of the
world may clarify if they are exclusive from our region.
CUT primer system showed a broader capacity in detecting HPVs
from different genera and species with respect to the FAP primer
system. As shown in Fig. 3, CUT primers were able to amplify HPV
types from ﬁve different species of the Alpha-, three from the Beta-,
and four from the Gamma-PV genera. Instead, FAP primer systemwas
more speciﬁc in detecting HPV types from the Beta-and the Gamma-
PV genera as well as Mu-PV genus. These data indicate that CUT and
FAP primer systems used in combination cover comprehensively all
cutaneous HPV types.
Using both primer systems we explored the HPV prevalence and
type spectrum in 71 immunocompetent subjects with different kinds
of skin diseases (Table 2). Since our main objective was to know the
HPV types circulating in our region, we did not use “stripping” to
reduce surface contamination of HPV. This approach and the low
Fig. 3. HPV types/putative types detected with CUT and FAP primer systems according to genera and species. Un: Undeﬁned Gamma-PV species (de Villiers et al., 2004).
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an association with any particular pathology. Still, the low prevalence
on HPV infection and the reduced number of viruses found in lesion
biopsies were in agreement with other studies in which “stripping”
was performed (Forslund et al., 2004; Forslund et al., 2007). The
analysis of skin samples from immunosuppressed individuals, such as
organ transplant recipients and HIV-infected subjects, may provide
additional data about the HPV spectrum circulating in our region.
One interesting result of our study that corroborate the inﬂuence
of UV radiation in HPV infection observed by others (Antonsson et al.,
2000; Forslund et al., 2007) was the signiﬁcantly higher HPV DNA
prevalence and the number of viruses involved in healthy skin sites
that are exposed with respect to those less exposed to the sun.
However, these ﬁndings must be interpreted with caution since we
also found signiﬁcantly more β-globin-negative samples among
healthy non-sun-exposed areas than in sun-exposed sites
(pb0.0001). Therefore, we cannot exclude that in the healthy
epithelium, a combination of low levels of viral DNA close to the
detection limit (Nindl et al., 2007) and a smaller amount of cellular
material in non-sun-exposed sites may be the cause of these
differences.
Phylogenetic analysis based on partial L1 sequences of the 17 novel
putative types (Fig. 4A) grouped them into Beta-PV (GC02, GC17),
Gamma-PV (GC01, GC04 to GC16) and Mu-PV (GC03) genera,
according to the current HPV taxonomy (de Villiers et al., 2004).
However, species deﬁnition based on nucleotide identities above 71%
to the HPV type representing each species could be determined only
in ﬁve isolates (Fig. 4B): GC02, GC03, GC11, GC15 and GC17. A large
genetic diversity within the Beta-PV and Gamma-PV genera has been
observed by others (Forslund, 2007), with most of putative HPV types
within the genus Gamma-PV segregated outside the deﬁned species.
Moreover, the recent characterization of three novel HPVs isolated
from cervical mucosa and related to genus Gamma-PV (Chen et al.,
2007; Nobre et al., 2009) provides additional insights into the natural
history of these viruses. Efforts directed toward identifying full-length
genomes of putative HPV types are required to have a complete
picture of the Papillomaviridae family. With this in mind, we
characterized the full-length genome of HPV 115 from isolate GC02
using an overlapping PCR method. GC02 sequence was initially
identiﬁed by sequencing a CUT-fragment from a sun-exposed healthy
skin sample derived from a patient of the viral wart group. Later, GC02
and its subtype revealed to be the most prevalent novel putative HPV
type among those found in our study (Tables 1 and 2).
Genome organization of HPV 115, with seven ORFs and lack of the
E5 ORF (Figs. 5A and C), resembled that of other HPV types in the same
genus (de Villiers and Gunst, 2009; Feltkamp et al., 2008). Its putative
proteins showed typical features of cutaneous HPV types (Vasiljevic et
al., 2007; Vasiljevic et al., 2008). As HPV 75, HPV 76, and HPV 49, the
E7 protein of HPV 115 contain only the second CXXC motif at the C-
terminal. It has been shown that HPV 16 E7 mutants or fragments
containing only the CXXC motif can still bind zinc (Rawls et al., 1990)and it is this motif which is essential for the immortalization of human
keratinocytes (Jewers et al., 1992), as well as for the transactivation
function of E7 (Storey et al., 1990; Watanabe et al., 1990). In addition,
the presence of a pRb-binding motif within the E7 ORF may suggest a
possible role for HPV 115 in skin carcinogenesis that deserves further
study.
Phylogenetic analysis of the complete L1 ORF indicates HPV 115 as
the fourth HPV type within the genus Beta-PV species 3, related to a
common ancestor of the three already known types (Fig. 5B). It is
interesting to note that this phylogenetic tree, based on an
evolutionary model of coding sequences with variable evolution
rates among them, had 100% posterior probability for all nodes,
implying fully statistical consistence for the alignment and the tree.
This observation was further supported by the high genetic diversity
obtained in the URR and in most ORFs of HPV 115 with respect to the
other members of genus Beta-PV species 3 (Fig. 5C). Taking into
account that HPV 49, HPV 75 and HPV 76 shared nucleotide identities
in all ORFs above 77% among them (Delius et al., 1998), HPV 115 can
be considered the less closely related member of genus Beta-PV
species 3.
In conclusion, we designed and applied a new generic primer
system that can be used in combination to the widely used FAP
primers to cover comprehensively all cutaneous HPV types. The
characterization of HPV 115 expands our knowledge of the hetero-
geneity of members of species 3 of the genus Beta-PV. However, a
large number of additional putative types exist within the Papillo-
maviridae family and much more effort will be required to elucidate
the medical implications of these viruses.
Materials and methods
Patients and data collection
A prospective study was conducted from June 2007 to December
2008 to address the HPV prevalence and type distribution in NMSCs
and premalignant and benign skin lesions at the Hospital Provincial
del Centenario. This public general hospital is located in Rosario City
(Argentina) and it services the metropolitan area as well as
neighboring towns in the Southern Santa Fe province. The study
base was deﬁned as patients seeking medical care at the División de
Dermatología of the Hospital, where surgical removal of a skin lesion
was medically indicated. The study adhered to the Declaration of
Helsinki and was approved by the Institutional Review Boards of the
Facultad de Ciencias Bioquímicas y Farmacéuticas (ﬁle 6060/048),
and of the Hospital Provincial del Centenario (ﬁle 036245-S). All
subjects provided informed consent and were interviewed about
demographic information (age, sex, place of birth), skin type (I–IV)
according to the Fitzpatrick classiﬁcation (Fitzpatrick, 1988), history
of skin cancer and family history of skin cancer. Enrolled patients
received a full skin examination carried out by a dermatologist and
the ﬁnal diagnosis was performed by histology.
Fig. 4. Phylogeny and nucleotide identities of the novel putative HPV types respect to reference HPVs. (A) Phylogenetic analysis of partial L1 ORF sequences (~370 bp for CUT and
∼235 bp for FAP) from the 17 novel putative HPV types identiﬁed in this study and 43 reference HPVs from genera Alpha-, Beta-, Gamma- and Mu-PVs. MrBayes settings: lset
nucmodel=codon; prset ratepr=variable; report possel=yes; mcmc ngen=800,000 nchains=2 printfreq=50 samplefreq=50. The ﬁrst 4.25×105 states were burned. The
numbers on the branches indicate the bipartition probabilities calculated by the 50% majority rule. Novel putative HPV types are indicated with a solid dot. The outer circle
encompasses genera and the inner circle indicates species. (B) Pairwise nucleotide identities (%) between novel putative HPV types and HPV types representing each species within
Beta-, Gamma- andMu-PV genera. Sequences of subtype GC02 (nucleotides 6011 to 6343 of FJ947080) and variants GC07.1 (FJ969899) and GC12.1 (FJ969907) were used to perform
both analysis. Numbers in bold indicate nucleotide identities above 71% for species deﬁnition according to the current HPV taxonomy (de Villiers et al., 2004).
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Fig. 5. Characterization of HPV 115, a novel Beta-PV species 3. (A) Genome organization of HPV 115 based on putative ORFs. (B) Phylogenetic tree of HPV 115 and 14 representative
HPVs of genus Beta-PV based on full-length L1 ORF sequences, using as the outgroup an Alpha-PV (HPV 16). MrBayes settings: lset nucmodel=codon; prset ratepr=variable; report
possel=yes; mcmc ngen=600,000 nchains=3 printfreq=100 samplefreq=100. The ﬁrst 4×105 states were burned. The numbers on the branches indicate the bipartition
probabilities calculated by the 50% majority rule. (C) Sizes of putative proteins encoded by the putative ORFs of HPV 115, their nucleotide positions and nucleotide identities (%) to
the other HPV types within genus Beta-PV species 3. aa: amino acids; nt: nucleotides.
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Five samples were collected from each patient from the
following areas: (A) healthy skin from a sun-exposed area
(forehead), (B) healthy skin from a non-sun-exposed area (upper
inner arm), (C) perilesion area, (D) lesion area, and (E) punch
biopsy from the lesion. Samples A to D were collected from
superﬁcial cells in the corresponding areas with sterile cotton-
tipped swabs pre-wetted in saline solution (0.9% NaCl). Swabs were
drawn and forth 10 times over the skin within an area of 5×5 cm,
and then suspended in 1 ml of saline. Each swab was agitated and
then discarded. Cells were centrifuged at 13,000×g for 5 min,
pellets were resuspended in 100 μl TE buffer containing 100 μgproteinase K and then incubated overnight at 55°C. After proteinase
K inactivation at 95°C for 10 min, cell lysates were stored at −20°C
until tested.
For collection of sample E, a 2 mm diameter punch biopsy was
taken from the lesion and divided into halves. One half was placed in
10% neutral buffered formalin for histopathologic evaluation (hema-
toxylin and eosin stain) at the División de Anatomía Patológica, and
the other half was processed for HPV DNA detection. Brieﬂy, biopsies
were digested in 200 μl of TE buffer containing 100 μg of proteinase K
and incubation overnight at 55°C. After proteinase K inactivation,
specimens were stored at−20°C until testing. The adequacy of swab
and biopsy samples was tested by PCR ampliﬁcation of the human β-
globin gene (Saiki et al., 1986) in all samples.
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desk and the stretcher at different times. All control swabs except one
were negative for the β-globin gene, and all of them were HPV-
negative.
CUT primer system design
DNA sequences from the L1 open reading frame (ORF) of 88
characterized cutaneotropic and mucosotropic HPVs that are listed at
the National Center for Biotechnology Information (http://www.ncbi.
nlm.nih.gov/) were aligned using Clustal X and visual inspection with
Mega version 4 (Tamura et al., 2007). Primer candidates obtained
with the Prima-Clade program (http://www.umsl.edu/services/
kellogg/primaclade.html) were compared to ﬁnd those presenting
lesser mismatches and then analyzed for primer-dimer and primer-
hairpin formations. Five primers were selected: CUT1Fw (TRCCi-
GAYCCiAATAARTTTG), CUT1AFw (TRCCiGAYCCiAACAGRTTTG),
CUT1BFw (TRCCiGAYCCiAATAGRTTTG), CUT1CFw (TRCCiGAYCCiAA-
CAARTTTG), and CUT1BRv (TCiACCATRTCiCCRTCYT). The alignment
of the 88 HPV types used to design the CUT primer system and the
positions of the primer binding regions are shown in Fig. 1A. The
positions of the forward and reverse primers corresponded to
nucleotides 6052–6072 and 6406–6424, respectively, of the HPV 10
genome (GenBank accession No. NC_001576), yielding an amplicon of
370 bp (Fig. 1B). Primers CUT1Afw, CUT1BFw and CUT1CFw were
prepared as amix (mix CUT1ABCFw) and used in low concentration in
PCR reactions as a complement of primer CUT1Fw (see below).
Single tube ‘hanging droplet’ PCRs
To improve the sensitivity for detection of HPV DNA and to
minimize the risk of cross contamination, ampliﬁcations with CUT or
FAP primer systems were assessed using the single tube “hanging
droplet” nested PCR technique developed by Walsh et al. (2001), in
the conditions described below. A thermocycler Mastercycler Person-
al (Eppendorf, Hamburg, Germany) was used in all the experiments
involving PCR.
CUT primer system
The primary 20 μl reaction mixture was placed in a reaction tube
and covered with one-drop of mineral oil. After addition of 5 μl
sample, the mixture had a ﬁnal volume of 25 μl containing 0.06 μM of
CUT1Fw, 0.04 μM of mix CUT1ABCFw (0.013 μM each) and 0.1 μM of
CUT1BRv, 200 μM of each dNTP (Fermentas, St. Leon-Rot, Germany),
3.5 mM MgCl2, 1.5× PCR buffer with (NH4)2SO4 (Fermentas) and 1 U
Taq DNA polymerase (Fermentas). Before the tube was closed, a 25 μl
droplet, containing the same reaction mixture [but with 0.42 μM of
CUT1Fw, 0.18 μM of mix CUT1ABCFw (0.06 μM each), 0.6 μM of
CUT1BRv, 400 μM of each dNTP and 2.5 U Taq DNA polymerase], was
placed in the centre of the inside of the reaction tube cap. Using the
thermocycler programmed for block temperature without heated lid,
themixture was heated for 2min at 94°C, followed by 20 cycles of 30 s
at 94°C, 2 s at 60°C followed by a ramp of 0.2°C/s to 55°C, 55°C for 10
and 40 s at 72°C. After the ﬁrst round of ampliﬁcation, the “hanging
droplet” was incorporated into the reaction mixture (ﬁnal volume 50
μl) by centrifugation 1 min (11,000×g) and a second round of 40
cycles (30 s at 94°C, 2 s at 60°C followed by a ramp of 0.2 °C/s to 52°C,
52°C for 10 and 40 s at 72°C) was performed.
FAP primer system
HPV DNA ampliﬁcation using FAP59/FAP64 outer primers (For-
slund et al., 1999) and FAP6085F/FAP6319R inner primers (Fig. 1B)
was performed as previously described (Forslund et al., 2003) except
for the thermocycling proﬁle, which was modiﬁed as follows: 2 min at94°C, followed by 20 cycles (ﬁrst round) or 40 cycles (second round)
of 30 s at 94°C, 2 s at 60°C followed by a ramp of 0.2°C/s to 50°C, 50°C
for 10 and 40 s at 72°C.
In each test, H2O without DNA and 5 ng human placental DNA
(Sigma, Buenos Aires, Argentina) were included as negative controls.
As positive controls, a 5 μl aliquot of 5 ng human placental DNA
solution containing 1000 copies of cloned HPV 10 for the CUT system
or 1000 copies of cloned HPV 20 for the FAP system were used.
For analytical sensitivity determination of each primer system, a
10-fold dilution series starting from 1000 copies of cloned HPV 10 or
HPV 20 were ampliﬁed in a background of 5 ng human placental DNA
(Sigma). Potential HPV amplicons were identiﬁed by size determina-
tion under UV light after electrophoresis in 2% agarose gel and
ethidium bromide staining. In the described conditions, the limit of
detection of CUT and FAP primer systems was of 10 copies of cloned
HPV 10 or HPV 20, respectively.
Cloning and DNA sequence analysis
Amplicons derived from CUT or FAP primer systems were puriﬁed
with a spin column (QIAquick PCR puriﬁcation kit, Qiagen, Hilden,
Germany) and eluted in 30 μl of elution buffer. DNA sequencing was
performed using sequencing facilities (University of Maine DNA
Sequencing Facility, USA) with reverse primers FAP6319R or
CUT1BRv. If the electropherogram suggested the presence of mixed
HPV types, cloning was performed with pGEM®-T Easy Cloning kit
(Promega, Madison, USA). Clones containing target inserts were
identiﬁed by PCR ampliﬁcation using M13 Fw/Rv primers. At least
three recombinant clones were sequenced from each sample.
Sequences were compared to available HPV-sequences in the
GenBank database by using Blast. A new putative HPV type was
deﬁned when the L1 fragment sequence showed less than 90%
sequence identity, a subtype when it showed sequence identity
between 90% and 98% or a variant when presented sequence identity
between 98% and 99% to any of the previously known HPV types (de
Villiers et al., 2004). The putative previously unreported HPV types
were cloned and fully sequenced on both DNA strands for complete
identiﬁcation.
Phylogenetic analysis
Protein sequence-derived nucleotide multiple alignments and
pairwise alignments were performed with Mega version 4 (Tamura
et al., 2007), and phylogenetic relationships were inferred by Bayesian
analysis using MrBayes 3.1 program (Huelsenbeck and Ronquist,
2001). To do so, Markov Chain Monte Carlo simulations were
performed during at least 8×105 generations, sampling one state
every 50 generations. Evolutionary model for each run was set as
indicates in the legend of ﬁgures. The number of states to be burned
was determined by the conﬂuence tests, and the remaining were
recovered and taken as stable likelihood ones. These states were used
for determining phylogenetic relationships, branch length and
posteriori probability for each branch. When simulations took too
much time to arrive to conﬂuence, a slightly modiﬁed neighbor-
joining tree was used as seed.
For the phylogenetic analysis of novel putative HPV types GC01 to
GC17, L1 gene sequences ampliﬁed with the different primer systems
were used. The following HPVs were included in the analysis: HPV 1,
4, 5, 8, 9, 12, 14, 15, 17 to 25, 36, 37, 38, 39, 45, 47, 48, 49, 50, 59, 60, 63,
65, 68, 70, 75, 76, 80, 88, 92, 93, 95, 96, 101, 103 and RTRX7. For the
phylogenetic analysis of HPV 115, full length L1 ORF sequences from
representative HPV types of the Beta-PV genus were used, and an
Alpha-PV (HPV 16) was chosen as the outgroup. The sequence set
included Beta-PVs of species 1 (HPV 5, 8, 12, 14D, 19), 2 (HPV 15, 17,
22, 23), 3 (HPV 49, 75, 76), 4 (HPV 92) and 5 (HPV 96). All sequences
215D. Chouhy et al. / Virology 397 (2010) 205–216from the previously characterized HPV types were obtained from the
GenBank database.
Statistical analysis
The statistical analysis of categorical variables was performed by
McNemar's test, Cochran's test and Stuart–Maxwell's test. The
comparison of means was made through Kruskal–Wallis's test. p-
Values below 0.05 were regarded statistically signiﬁcant.
Identiﬁcation of the full-length genome of HPV 115
HPV 115 was isolated from a swab sample collected from a sun-
exposed healthy skin area derived from an immunocompetent male
from the viral wart group. HPV 115 was described in this study as the
PCR amplicon GC02. The complete genome sequence of the novel type
HPV 115 was obtained by generating overlapping amplicons in an
Expand Long Template PCR System (Roche, Buenos Aires, Argentina).
The 50 μl PCR solution contained 5 μl extracted DNA, 0.5 μM of each
forward and reverse primers, 0.5 mM each dNTP (Fermentas), 1×
Buffer III and 5 U Expand Long Template Enzyme mix. The following
primer pairs were used: 1DcutRv (5′-CAAGCCCAGACTAATCTTTCCTT-
3′) with E1-1732F (5′-CTTACTGACCAAAGCTGG-3′) (Vasiljevic et al.,
2007), and 1DcutFw (5′-TGATCCCAAACAGGTACAAATGT-3′) with
FA47.82CH-R (5′-TCTSCCTCGTCTTCTGGRTCAC-3′), targeting the E1
ORF of the genus Beta-PV. PCRs were performed using the following
cycling conditions: 2 min at 94°C followed by 15 cycles of 15 s at 94°C,
40 s at 50°C for annealing of the E1-1732F/1DcutRv primers or 58°C
for annealing of the 1DcutFw/FA47.82CH-R primers, and 4 min at
68°C; followed by 25 cycles of 15 s at 94°C, 40 s at the same
temperature as in the previous annealing step for each primer pair,
and 4 min at 68°C with an extra 20 s per cycle; and a ﬁnal incubation
at 68°C for 10 min. The ampliﬁed DNA fragments were separated by
electrophoresis in a 1% agarose gel (Biodynamics, Buenos Aires,
Argentina) in TE buffer. Two bands of approximately 4 kb were
excised and puriﬁed using a QIAquick Gel Extraction kit (Qiagen). All
the amplicons were cloned using a pGEM®-T Easy Cloning kit
(Promega). Clones and the corresponding complete sequences were
submitted to the International Reference Centre for Papillomaviruses
at the German Cancer Research Centre (Heidelberg, Germany), where
the complete genome was ofﬁcially designated HPV 115 (GenBank
accession No. FJ947080).
Nucleotide sequence accession numbers
HPV type candidate sequences GC01 to GC17 have been submitted
to GenBank with the following accession numbers: GC01 (FJ947079),
GC02 (nucleotides 6011 to 6343 of HPV 115, FJ947080), GC02b
(FJ947081), GC03 (FJ947082), GC04 (FJ969896), GC05 (FJ969898),
GC06 (FJ969897), GC07.1 (FJ969899), GC07.2 (FJ969900), GC07.3
(FJ969901), GC07.4 (FJ969902), GC08 (FJ969904), GC09 (FJ969903),
GC10 (FJ969905), GC11 (FJ969906), GC12.1 (FJ969907), GC12.2
(FJ969908), GC12.3 (FJ969909), GC13 (FJ969910), GC14 (FJ969911),
GC15 (FJ969912), GC16 (FJ969913) and GC17 (FJ969914).
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